X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2025-02-18 | ANNX | Dananberg Jamie | Chief Medical Officer | S - Sale | $2.96 | -5,521 | 33,479 | -14% | -$16,342 | ||||||
2025-02-18 | ANNX | Artis Dean Richard | EVP, CHIEF SCIENTIFIC OFFICER | S - Sale | $2.97 | -5,515 | 83,814 | -6% | -$16,380 | ||||||
2025-02-18 | ANNX | Yednock Ted | EVP, CHIEF INNOVATION OFFICER | S - Sale | $2.91 | -8,345 | 61,237 | -12% | -$24,284 | ||||||
2025-02-18 | ANNX | Overdorf Michael | EVP, CHIEF BUSINESS OFFICER | S - Sale | $2.95 | -6,618 | 86,579 | -7% | -$19,523 | ||||||
2025-02-18 | ANNX | Lew Jennifer | EVP, CFO | S - Sale | $2.92 | -6,912 | 77,770 | -8% | -$20,183 | ||||||
2025-02-13 | ANNX | Love Douglas | Pres, CEO | S - Sale | $2.95 | -5,021 | 351,554 | -1% | -$14,812 | ||||||
2025-02-13 | ANNX | Lew Jennifer | EVP, CFO | S - Sale | $2.98 | -1,786 | 84,682 | -2% | -$5,322 | ||||||
2025-02-13 | ANNX | Overdorf Michael | EVP, CHIEF BUSINESS OFFICER | S - Sale | $2.99 | -1,425 | 93,197 | -2% | -$4,261 | ||||||
2025-02-13 | ANNX | Yednock Ted | EVP, CHIEF INNOVATION OFFICER | S - Sale | $2.99 | -1,783 | 69,582 | -2% | -$5,331 | ||||||
2024-12-02 | ANNX | Carson William H. | Dir | P - Purchase | $5.33 | +3,200 | 25,600 | +14% | +$17,056 | ||||||
| D | 2024-10-15 | ANNX | Yednock Ted | EVP, CHIEF INNOVATION OFFICER | S - Sale+OE | $7.41 | -5,408 | 71,365 | -7% | -$40,073 | |||||
2024-10-01 | ANNX | Carson William H. | Dir | P - Purchase | $5.97 | +3,200 | 22,400 | +17% | +$19,104 | ||||||
2024-09-19 | ANNX | Yednock Ted | EVP, CHIEF INNOVATION OFFICER | S - Sale | $7.10 | -4,500 | 71,365 | -6% | -$31,950 | ||||||
2024-09-12 | ANNX | Yednock Ted | EVP, CHIEF INNOVATION OFFICER | S - Sale | $6.16 | -5,500 | 75,865 | -7% | -$33,880 | ||||||
2024-09-05 | ANNX | Yednock Ted | EVP, CHIEF INNOVATION OFFICER | S - Sale | $5.64 | -5,500 | 81,365 | -6% | -$31,020 | ||||||
2024-09-03 | ANNX | Carson William H. | Dir | P - Purchase | $5.48 | +3,200 | 19,200 | +20% | +$17,536 | ||||||
2024-08-29 | ANNX | Yednock Ted | EVP, CHIEF INNOVATION OFFICER | S - Sale | $5.95 | -5,500 | 86,865 | -6% | -$32,725 | ||||||
2024-08-01 | ANNX | Carson William H. | Dir | P - Purchase | $6.24 | +3,200 | 16,000 | +25% | +$19,968 | ||||||
2024-07-15 | ANNX | Overdorf Michael | EVP, CHIEF BUSINESS OFFICER | S - Sale | $6.02 | -784 | 94,622 | -1% | -$4,720 | ||||||
2024-07-15 | ANNX | Lew Jennifer | EVP, CFO | S - Sale | $6.03 | -1,104 | 86,468 | -1% | -$6,657 | ||||||
2024-07-15 | ANNX | Yednock Ted | EVP, CHIEF INNOVATION OFFICER | S - Sale | $6.02 | -1,106 | 92,365 | -1% | -$6,658 | ||||||
2024-07-01 | ANNX | Carson William H. | Dir | P - Purchase | $5.00 | +3,200 | 12,800 | +33% | +$16,000 | ||||||
2024-06-03 | ANNX | Carson William H. | Dir | P - Purchase | $4.83 | +3,200 | 9,600 | +50% | +$15,459 | ||||||
2024-05-01 | ANNX | Carson William H. | Dir | P - Purchase | $4.68 | +3,200 | 6,400 | +100% | +$14,982 | ||||||
2024-04-08 | ANNX | Carson William H. | Dir | P - Purchase | $6.07 | +3,200 | 3,200 | New | +$19,411 | ||||||
| D | 2024-02-20 | ANNX | Lew Jennifer | EVP, CFO | S - Sale+OE | $5.53 | -2,593 | 82,058 | -3% | -$14,339 | |||||
| D | 2024-02-20 | ANNX | Yednock Ted | EVP, CHIEF INNOVATION OFFICER | S - Sale+OE | $5.51 | -2,604 | 93,471 | -3% | -$14,348 | |||||
| D | 2024-02-20 | ANNX | Overdorf Michael | EVP, CHIEF BUSINESS OFFICER | S - Sale+OE | $5.48 | -1,951 | 85,641 | -2% | -$10,691 | |||||
2024-02-12 | ANNX | Overdorf Michael | EVP, CHIEF BUSINESS OFFICER | S - Sale | $5.53 | -1,349 | 48,592 | -3% | -$7,460 | ||||||
2024-02-12 | ANNX | Love Douglas | Pres, CEO | S - Sale | $5.54 | -5,782 | 196,121 | -3% | -$32,032 | ||||||
2024-02-12 | ANNX | Lew Jennifer | EVP, CFO | S - Sale | $5.54 | -1,809 | 45,651 | -4% | -$10,022 | ||||||
2024-02-12 | ANNX | Yednock Ted | EVP, CHIEF INNOVATION OFFICER | S - Sale | $5.54 | -1,810 | 57,075 | -3% | -$10,027 | ||||||
| AM | 2023-07-11 | ANNX | Yednock Ted | EVP, Chief Innovation Officer | S - Sale | $4.49 | -22,057 | 58,885 | -27% | -$99,021 | |||||
2023-07-11 | ANNX | Overdorf Michael | EVP, Chief Business Officer | S - Sale | $3.84 | -978 | 45,802 | -2% | -$3,752 | ||||||
2023-07-11 | ANNX | Lew Jennifer | EVP, CFO | S - Sale | $3.84 | -1,057 | 47,460 | -2% | -$4,055 | ||||||
| D | 2023-12-27 | ANNX | Yednock Ted | EVP, Chief Innovation Officer | S - Sale+OE | $4.52 | -21,000 | 0 | -100% | -$94,966 | |||||
2023-12-26 | ANNX | Satter Muneer A | Dir, 10% | P - Purchase | $2.88 | +350,000 | 7,406,024 | +5% | +$1,008,000 | ||||||
2023-05-25 | ANNX | Bain Capital Life Sciences Investors, LLC | 10% | P - Purchase | $2.13 | +300,000 | 5,701,926 | +6% | +$639,720 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |